An excellent read overall.
Nothing substantially new other than the new product roadmap. Ultimately, they are committed to growing long term shareholder value, reminiscent of what Xero said in their early letters to shareholders. A long road ahead.
Historically (and even still today), LVT was seen by the market and fund managers as having exotic levels of spend that they could not control as part of their "hyper-growth" plan. However, this announcement highlights that Karl and PNB are willing and able to make the very tough decisions around spend. Headcount has dropped by 25% as part of streamlining efforts.
They are in this for the long run and will continue to adapt their strategy as needed as the journey evolves.
A multi-billion dollar company in the making.
T.E.P.
- Forums
- ASX - By Stock
- LVT
- Ann: Founders Letter to Shareholders
Ann: Founders Letter to Shareholders, page-21
Featured News
Add LVT (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online